Prostate Cancer
📧 Sign up to get email alerts when something new happens for Prostate Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-10-01Clinical Trial Update: Genetic Testing for Men With Metastatic Prostate Cancer
The University of Washington–sponsored clinical trial evaluating genetic testing in men with metastatic prostate cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2025-09-29Clinical Trial Update: Exercise in Targeting Metabolic Dysregulation in Stage I-III Breast or Prostate Cancer Survivors [NA]
A clinical trial evaluating exercise to target metabolic dysregulation in stage I-III breast and prostate cancer survivors has been terminat…
-
CLINICAL_TRIALS trial_result · 2025-09-25Clinical Trial Update: 68Ga-NTA-476 Imaging in Prostate Cancer [EARLY_Phase 1]
An early-phase trial evaluating the 68Ga-NTA-476 imaging agent for detecting prostate cancer has completed.
-
CLINICAL_TRIALS trial_result · 2025-09-25Clinical Trial Update: A Dosimetry Study of Lutetium (177Lu) rhPSMA-10.1 and Lutetium (177Lu) Vipivotide Tetraxetan (Pluvicto®) in Patients With Non-curative Metastatic Prostate Cancer [EARLY_Phase 1]
Early Phase 1 dosimetry study of two Lutetium-177 radiopharmaceuticals (rhPSMA-10.1 and lutetium-177 vipivotide tetraxetan) in patients with…
-
CLINICAL_TRIALS trial_result · 2025-09-23Clinical Trial Update: Improving Quality of Life of Prostate Cancer Survivors With Androgen Deficiency [Phase 2]
Phase 2 clinical trial assessing interventions to improve quality of life in prostate cancer survivors with androgen deficiency; the study h…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-09-22Clinical Trial Update: RElugolix VErsus LeUprolide Cardiac Trial [Phase 2]
Phase 2 trial comparing Relugolix to Leuprolide in biochemically recurrent and localized prostate cancer; results have been posted as of 202…
-
CLINICAL_TRIALS trial_result · 2025-09-22Clinical Trial Update: Safety and Efficacy of Oral Testosterone Undecanoate Followed by Enzalutamide as Therapy for Men With Metastatic Castrate Resistant Prostate Cancer [Phase 2]
This Phase 2 trial evaluating sequential oral testosterone undecanoate followed by enzalutamide in men with metastatic castration-resistant …
-
CLINICAL_TRIALS trial_result · 2025-09-22Clinical Trial Update: Positron Emission Radiomics With PSMA Radioligands on Newly Diagnosed Prostate Cancer Patients
This clinical trial update reports a completed study on positron emission radiomics using PSMA radioligands in newly diagnosed prostate canc…
-
CLINICAL_TRIALS trial_result · 2025-09-16Clinical Trial Update: Retrospective Evaluation of Commercial Spacers in Prostate Cancer Patients
This study provides a retrospective evaluation of commercially available spacers used in prostate cancer patients undergoing radiotherapy, d…
-
CLINICAL_TRIALS trial_result · 2025-09-16Clinical Trial Update: Prospective Evaluation of a Commercially Available Hydrogel Spacer
Sponsored by BioProtect, this prospective evaluation of a commercially available hydrogel spacer for prostate cancer radiotherapy has comple…
-
CLINICAL_TRIALS trial_result · 2025-09-15Clinical Trial Update: Vudalimab (XmAb20717) in Combination With Standard of Care Treatment in Patients With Metastatic Castration Sensitive Prostate Cancer [Phase 1]
A Phase 1 trial evaluating Vudalimab (XmAb20717) in combination with standard of care for metastatic castration-sensitive prostate cancer wa…
-
CLINICAL_TRIALS trial_result · 2025-09-12Clinical Trial Update: Radioligand fOr locAl raDiorecurrent proStaTe cancER [Phase 1, Phase 2]
This clinical trial update notes the completion of Phase 1 and Phase 2 trials evaluating a radioligand therapy for locally radiorecurrent pr…
-
CLINICAL_TRIALS trial_result · 2025-09-11Clinical Trial Update: Intrapatient Comparison of Urinary Radioactivity Following Piflufolastat (18F) and Flotufolastat (18F) PET in Men With Low PSA Biochemical Recurrence of Prostate Cancer Following Radical Prostatectomy [Phase 4]
Phase 4 study comparing intrapatient urinary radioactivity between Piflufolastat F-18 and Flotufolastat F-18 PET imaging in men with low PSA…
-
CLINICAL_TRIALS trial_result · 2025-09-11Clinical Trial Update: Health Gatherings - For Your Health After Cancer [NA]
This clinical trial update from the University of Miami reports completed results for a study involving prostate and related male genital ca…
-
CLINICAL_TRIALS trial_result · 2025-09-11Clinical Trial Update: Schedule De-Escalation of 177Lu-PSMA-617 for the Treatment of Metastatic Castrate Resistant Prostate Cancer [Phase 2]
This clinical trial update describes a Phase 2 study evaluating schedule de-escalation of 177Lu-PSMA-617 for metastatic castration-resistant…
-
CLINICAL_TRIALS trial_result · 2025-09-11Clinical Trial Update: PYLARIFY® PET/CT or PET/MRI in Men With Favorable Intermediate Risk (FIR) Prostate Cancer [Phase 4]
A Phase 4 clinical trial update indicates that PYLARIFY PET/CT or PET/MRI is being studied in men with favorable intermediate-risk prostate …
-
CLINICAL_TRIALS trial_result · 2025-09-10Clinical Trial Update: A Study to Evaluate the Effect of Rifampicin on the Pharmacokinetics of Oral HRS-5041 in Healthy Subjects [Phase 1]
A Phase 1 pharmacokinetic interaction study evaluating the effect of rifampicin on the PK of oral HRS-5041 in healthy subjects has been comp…
-
CLINICAL_TRIALS trial_result · 2025-09-10Clinical Trial Update: A Trial for a Preliminary Estimate of the Effectiveness of a Novel Theoretical Framework [NA]
This completed clinical trial from the University of Arkansas provides a preliminary estimate of the effectiveness of a novel theoretical fr…
-
CLINICAL_TRIALS trial_result · 2025-09-10Clinical Trial Update: A Study on the Safety and Efficacy of LAE001 in the Treatment of Metastatic Prostate Cancer [Phase 1, Phase 2]
A terminated Phase 1/2 study evaluating the safety and efficacy of LAE001 in metastatic prostate cancer.
-
CLINICAL_TRIALS trial_result · 2025-09-10Clinical Trial Update: AGN-CognI.Q Acute Dose Safety and Pharmacokinetics Dose-Response in Prostate Cancer Patients [Phase 1]
Phase 1 study evaluating the safety and pharmacokinetics (acute dose, dose-response) of AGN-CognI.Q in prostate cancer patients. The study s…
-
CLINICAL_TRIALS trial_result · 2025-09-09Clinical Trial Update: Effects of Triptorelin Pamoate 6-month When Given to Adult Chinese Participants With Advanced Cancer in the Prostate [Phase 3]
Phase 3 trial evaluating a 6-month regimen of triptorelin pamoate in adult Chinese men with advanced prostate cancer; results have been post…
-
CLINICAL_TRIALS trial_result · 2025-09-08Clinical Trial Update: Dietary Fiber During Radiotherapy - a Placebo-controlled Randomized Trial [Phase 3]
Phase 3 randomized, placebo-controlled trial evaluating dietary fiber during radiotherapy in cancer patients has completed.
-
CLINICAL_TRIALS trial_result · 2025-09-08Clinical Trial Update: Comparative Study of Diagnostic and Prognosis Biomarkers of Prostate Cancer in Liquid Biopsy (HOPE) [NA]
This clinical trial update notes the completion of the HOPE study, which compares diagnostic and prognostic biomarkers for prostate cancer u…
-
CLINICAL_TRIALS trial_result · 2025-09-08Clinical Trial Update: Clinical Study on Neoadjuvant Therapy of Homoharringtonine Combined With Androgen Deprivation for Prostate Cancer [Phase 2]
Phase 2 clinical study evaluating neoadjuvant therapy with homoharringtonine in combination with androgen deprivation for prostate cancer; r…
-
CLINICAL_TRIALS trial_result · 2025-09-05Clinical Trial Update: Study of Dose Escalation of Abiraterone Actetate in Prostate Cancer [Phase 2]
A Phase 2 dose-escalation trial of Abiraterone Acetate in prostate cancer has completed.